Ohm Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OHM LABS INC, and what generic and branded alternatives to OHM LABS INC drugs are available?
OHM LABS INC has three approved drugs.
There is one tentative approval on OHM LABS INC drugs.
Summary for Ohm Labs Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Ohm Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ohm Labs Inc | VALSARTAN | valsartan | TABLET;ORAL | 077492-003 | Jun 26, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ohm Labs Inc | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209254-001 | Jul 16, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ohm Labs Inc | EZETIMIBE | ezetimibe | TABLET;ORAL | 207311-001 | Jun 12, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ohm Labs Inc | VALSARTAN | valsartan | TABLET;ORAL | 077492-001 | Jun 26, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ohm Labs Inc | GUAIFENESIN | guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209254-002 | Jul 16, 2018 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
